Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

Kiniksa Pharmaceuticals International, plc

KNSA · Nasdaq · CIK 0001730430 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

61 Form 4 transaction lines observed in the same window
12 sales · 49 option, withholding, award, gift or other lines

Last qualifying purchaseNo qualifying purchase is present in the local Form 4 history.

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Patel Sanj KCHAIRMAN & CEO
○▼○▼○○○○○
Megna Michael RCHIEF ACCOUNTING OFFICER
○○○▼
Paolini John F.CHIEF MEDICAL OFFICER
○▼○○
Cole G BradleyDirector
○○▼
Ragosa MarkCHIEF FINANCIAL OFFICER
○○
Moat RossCHIEF OPERATING OFFICER
○○
● Purchase▼ Sale○ Other

Showing the six most active owners; 6 additional owner(s) remain in Form 4 evidence.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot.—

Recent Form 4 activity

0Purchases
45Sales
109Other Form 4 lines
54SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING12 sale line(s) · context only
OTHER49 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
3,778,657
Previous report
3,876,769
Avg daily volume
589,057
Days to cover
6.4

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

No qualifying code P equity purchase is present in the local Form 4 history.

Form 4 evidence

154 transaction lines in the latest 365-day window; 706 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-03Megna Michael RSale (S)Class A Ordinary Share4,600USD 80.30USD 369,380SEC filing ↗
2026-09-01Ragosa MarkOption exercise / conversion (M)Class A Ordinary Share9,104USD —USD —SEC filing ↗
2026-09-01Ragosa MarkTax withholding (F)Class A Ordinary Share4,404USD 79.28USD 349,149SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-03Megna Michael RSale (S)Class A Ordinary Share4,600USD 80.30USD 369,380SEC filing ↗
2026-09-01Ragosa MarkOption exercise / conversion (M)Class A Ordinary Share9,104USD —USD —SEC filing ↗
2026-09-01Ragosa MarkTax withholding (F)Class A Ordinary Share4,404USD 79.28USD 349,149SEC filing ↗
2026-09-01Patel Sanj KOption exercise / conversion (M)Class A Ordinary Share31,318USD —USD —SEC filing ↗
2026-09-01Patel Sanj KOption exercise / conversion (M)Class A Ordinary Share31,318USD —USD —SEC filing ↗
2026-09-01Patel Sanj KTax withholding (F)Class A Ordinary Share15,144USD 79.28USD 1,200,616SEC filing ↗
2026-09-01Patel Sanj KTax withholding (F)Class A Ordinary Share15,144USD 79.28USD 1,200,616SEC filing ↗
2026-09-01Paolini John F.Option exercise / conversion (M)Class A Ordinary Share8,328USD —USD —SEC filing ↗
2026-09-01Paolini John F.Tax withholding (F)Class A Ordinary Share4,029USD 79.28USD 319,419SEC filing ↗
2026-09-01Moat RossOption exercise / conversion (M)Class A Ordinary Share8,285USD —USD —SEC filing ↗
2026-09-01Moat RossTax withholding (F)Class A Ordinary Share4,007USD 79.28USD 317,675SEC filing ↗
2026-09-01Megna Michael ROption exercise / conversion (M)Class A Ordinary Share11,496USD —USD —SEC filing ↗
2026-09-01Megna Michael RTax withholding (F)Class A Ordinary Share5,531USD 79.28USD 438,498SEC filing ↗
2026-08-19Quart Barry DGift (G)Class A Ordinary Share2,600USD 0.00USD 0SEC filing ↗
2026-08-01Levy Richard SOption exercise / conversion (M)Class A Ordinary Share403USD —USD —SEC filing ↗
2026-07-29Cole G BradleySale (S)Class A Ordinary Share3,673USD 81.43USD 299,092SEC filing ↗
2026-07-29Cole G BradleyGift (G)Class A Ordinary Share4,500USD 0.00USD 0SEC filing ↗
2026-07-15Megna Michael RAward / grant (A)Class A Ordinary Share279USD 33.50USD 9,346SEC filing ↗
2026-06-01Patel Sanj KC (C)Class A Ordinary Share900,000USD —USD —SEC filing ↗
2026-05-29Quart Barry DOption exercise / conversion (M)Class A Ordinary Share2,799USD —USD —SEC filing ↗
2026-05-29Popovits Kimberly JOption exercise / conversion (M)Class A Ordinary Share2,799USD —USD —SEC filing ↗
2026-05-29McCain Tracey LOption exercise / conversion (M)Class A Ordinary Share2,799USD —USD —SEC filing ↗
2026-05-29Malley ThomasOption exercise / conversion (M)Class A Ordinary Shares2,799USD —USD —SEC filing ↗
2026-05-29Levy Richard SOption exercise / conversion (M)Class A Ordinary Share2,799USD —USD —SEC filing ↗
2026-05-29Cole G BradleyOption exercise / conversion (M)Class A Ordinary Share2,799USD —USD —SEC filing ↗
2026-05-29667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPAward / grant (A)Class A Ordinary Shares6,078USD 0.00USD 0SEC filing ↗
2026-05-01Paolini John F.Sale (S)Class A Ordinary Share58,424USD 53.71USD 3,137,823SEC filing ↗
2026-05-01Paolini John F.Option exercise / conversion (M)Class A Ordinary Share58,424USD 10.36USD 605,273SEC filing ↗
2026-05-01Patel Sanj KSale (S)Class A Ordinary Share48,565USD 54.02USD 2,623,481SEC filing ↗
2026-05-01Patel Sanj KOption exercise / conversion (M)Class A Ordinary Share48,565USD 30.93USD 1,502,115SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerKNSA
CIK0001730430
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history706 transaction lines from 2020-02-13 to 2026-09-03
0 P purchase lines · 177 S sale lines · 529 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.